A monkey study of CAR T-cells and HIV: What you need to knowHealthNewsReview.orgCAR-T drugs, HIV. Michael Joyce is a writer-producer with HealthNewsReview.org and tweets as @mlmjoyce. A news release about a gene therapy that tantalizes with the phrase … Continue reading
FierceBiotech |
Gene therapy temporarily reverses diabetes in mice
FierceBiotech The team used an adeno-associated viral (AAV) vector—the same technology that’s at the heart of Spark’s gene therapy—to deliver two proteins, Pdx1 and MafA, into the pancreas. These proteins “reprogrammed” alpha cells into insulin-producing cells … Could Gene Therapy One Day Cure Diabetes?Gizmodo |
Gizmodo |
Could Gene Therapy One Day Cure Diabetes?
Gizmodo If we use gene therapy to get the body to make new insulin-producing cells in the body, logically it should attack those cells too.” But that’s not what happened. Using what’s known as an adeno-associated virus, they deliver two proteins, Pdx1 and MafA … Gene therapy temporarily reverses diabetes in miceFierceBiotech Gene therapy restores normal blood glucose levels in mice with type 1 diabetesEurekAlert (press release) |
|
Efficacy and safety of chimeric antigen receptor T–cell (CAR-T) therapy in patients with haematological and solid …
UroToday Patients with relapsed or refractory malignancies have a poor prognosis. Immunotherapy with chimeric antigen receptor T (CAR–T) cells redirects a patient’s immune cells against the tumour antigen. CAR–T cell therapy has demonstrated promise in treating … |
Live Science |
Can Gene Editing Save the World’s Chocolate?
Live Science Fungi and viruses are poised to doom chocolate, which is why scientists are racing to save cacao — the tree that sprouts the colorful, football-size pods containing beans used to make chocolate — with the gene-editing tool known as CRISPR-Cas9 … |
nwitimes.com |
Here’s What Pushed Crispr Therapeutics AG Up 23.6% in December
nwitimes.com Shares of Crispr Therapeutics AG (NASDAQ: CRSP), a biotech start-up named after the promising new gene-editing technology it’s focused on, bounded 23.6% higher in December, according to data from S&P Global Market Intelligence. A new collaboration deal … CRISPR Therapeutics Announces Proposed Public Offering of …GlobeNewswire (press release) A Comparison of Top Movers: Overstock.com, Inc. (OSTK), CRISPR Therapeutics AG (CRSP)StockNewsGazette Head-To-Head Contrast: Crispr Therapeutics (CRSP) vs. Incyte (INCY)Dispatch Tribunal The Lincolnian Online –The Ledger Gazette all 31 news articles » |